Comerica Bank
PBYI icon

Comerica Bank’s Puma Biotechnology PBYI Stock Holding History

Comerica Bank’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,088
Closed -$217K – 2184
2014
Q1 		$217K Buy
2,088
+10
+0.5% +$1.18K ﹤0.01% 2134
2013
Q4 		$215K Buy
+2,078
New +$122K ﹤0.01% 2124

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Comerica Bank's PBYI Position: Q2 2014 in Review

Comerica Bank sold out of Puma Biotechnology (PBYI) in Q2 2014, closing a stake of 2,088 shares — an estimated $217K sold.

Comerica Bank first reported a position in PBYI in Q4 2013 and held it in 2 quarters. The position peaked at $217K in Q1 2014. 138 funds tracked by Wall St. Rank hold PBYI as of Q2 2014.

  • Comerica Bank reported no remaining Puma Biotechnology position as of Q2 2014 after selling out during the quarter.
  • Comerica Bank sold 2,088 Puma Biotechnology shares in Q2 2014, an estimated $217K.
  • Comerica Bank first reported a position in Puma Biotechnology in Q4 2013 and held it in 2 quarters.
  • Comerica Bank's Puma Biotechnology position peaked at $217K in Q1 2014.
  • 138 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2014.

Based on Comerica Bank's 13F filing for Q2 2014, filed 12 Aug 2014.